Abstract
Biomaterials should be designed to closely resemble the characteristics and functions of the native extracellular matrix to provide mechanical support and signals to direct biological events. Here we have developed a novel injectable plasma rich in growth factors (PRGF-Endoret)-based formulation that combines a thermal-denaturation step of plasma with an autologous fibrin crosslinking. Rheological and mechanical properties were evaluated. Additionally, the microstructure and biological capacity of the biomaterial was also characterized. This novel formulation exhibited ideal mechanical properties and a gel-like behavior with the ability to progressively release its growth factor load over time. The results also suggested that the novel injectable formulation is non-cytotoxic, biocompatible and suitable for cell ingrowth as it is deduced from the fibroblast proliferation within the scaffold. Finally, stimulation of both cell proliferation and matrix proteins synthesis demonstrated the regenerative potential of this autologous protein based injectable scaffold.
Graphical abstract
Similar content being viewed by others
References
Davidenko N, Schuster CF, Bax DV, Raynal N, Farndale RW, Best SM, et al. Control of crosslinking for tailoring collagen-based scaffolds stability and mechanics. Acta biomaterialia. 2015;25:131–42. https://doi.org/10.1016/j.actbio.2015.07.034.
Garg T, Singh O, Arora S, Murthy R Scaffold: a novel carrier for cell and drug delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2012;29:1–63
Yue K, Trujillo-de Santiago G, Alvarez MM, Tamayol A, Annabi N, Khademhosseini A. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials. 2015;73:254–71. https://doi.org/10.1016/j.biomaterials.2015.08.045
Paluch EK, Nelson CM, Biais N, Fabry B, Moeller J, Pruitt BL, et al. Mechanotransduction: use the force(s). BMC biology. 2015;13:47. https://doi.org/10.1186/s12915-015-0150-4
Carey SP, Charest JM, Reinhart-King CA. (2010). Forces during cell adhesion and spreading: Implications for cellular homeostasis. In: Gefen A, editors. Cellular and biomolecular mechanics and mechanobiology. New York: Springer; 2010. p. 29–69. https://doi.org/10.1007/8415_2010_22
Lee K, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. Journal of the Royal Society, Interface / the Royal Society. 2011;8:153–70. https://doi.org/10.1098/rsif.2010.0223
Whitaker M, Quirk R, Howdle S, Shakesheff K. Growth factor release from tissue engineering scaffolds. Journal of Pharmacy and Pharmacology. 2001;53:1427–37.
Bellas E, Lo TJ, Fournier EP, Brown JE, Abbott RD, Gil ES, et al. Injectable silk foams for soft tissue regeneration. Advanced healthcare materials. 2015;4:452–9. https://doi.org/10.1002/adhm.201400506
Solouk A, Mirzadeh H, Amanpour S. Injectable scaffold as minimally invasive technique for cartilage tissue engineering: in vitro and in vivo preliminary study. Progress in Biomaterials. 2014;3:143–51. https://doi.org/10.1007/s40204-014-0031-x
Lee JH, Oh H, Baxa U, Raghavan SR, Blumenthal R. Biopolymer-connected liposome networks as injectable biomaterials capable of sustained local drug delivery. Biomacromolecules. 2012;13:3388–94. https://doi.org/10.1021/bm301143d
Pierre S, Liew S, Bernardin A. Basics of dermal filler rheology. Dermatologic surgery. 2015;41(Suppl 1):S120–S126. https://doi.org/10.1097/DSS.0000000000000334.
Gutowska A, Jeong B, Jasionowski M. Injectable gels for tissue engineering. The Anatomical record. 2001;263:342–9.
Kretlow JD, Klouda L, Mikos AG. Injectable matrices and scaffolds for drug delivery in tissue engineering. Advanced Drug Delivery Reviews. 2007;59:263–73. http://dx.doi.org/10.1016/j.addr.2007.03.013
Anitua E, Muruzabal F, Tayebba A, Riestra A, Perez VL, Merayo-Lloves J, et al. Autologous serum and plasma rich in growth factors in ophthalmology: preclinical and clinical studies. Acta ophthalmologica. 2015;93:e605–14. https://doi.org/10.1111/aos.12710
Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. Journal of controlled release: official journal of the Controlled Release Society. 2012;157:29–38. https://doi.org/10.1016/j.jconrel.2011.07.004
Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. International journal of Oral and maxillofacial Implants. 1999;14:529–35.
Spicer PP, Mikos AG. Fibrin glue as a drug delivery system. Journal of controlled release: official journal of the Controlled Release Society. 2010;148:49–55. https://doi.org/10.1016/j.jconrel.2010.06.025
Li Y, Meng H, Liu Y, Lee BP. Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineering. TheScientificWorldJournal. 2015;2015:685690. https://doi.org/10.1155/2015/685690
Ahmed TA, Dare EV, Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue engineering Part B, Reviews. 2008;14:199–215. https://doi.org/10.1089/ten.teb.2007.0435
Eyrich D, Brandl F, Appel B, Wiese H, Maier G, Wenzel M, et al. Long-term stable fibrin gels for cartilage engineering. Biomaterials. 2007;28:55–65. http://dx.doi.org/10.1016/j.biomaterials. 2006.08.027
Wang X, Luo Y, Masci PP, Crawford R, Xiao Y. Influence of Interleukin-1 Beta on Platelet-Poor Plasma Clot Formation: A Potential Impact on Early Bone Healing. PloS one. 2016;11:e0149775. https://doi.org/10.1371/journal.pone.0149775
Anitua E, Sanchez M, Zalduendo MM, de la Fuente M, Prado R, Orive G, et al. Fibroblastic response to treatment with different preparations rich in growth factors. Cell proliferation. 2009;42:162–70. https://doi.org/10.1111/j.1365-2184.2009.00583.x
Anitua E, Zalduendo M, Troya M, Orive G. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells. Clinical oral investigations. 2016;20:513–21. https://doi.org/10.1007/s00784-015-1528-y
Colella AD, Chegenii N, Tea MN, Gibbins IL, Williams KA, Chataway TK. Comparison of Stain-Free gels with traditional immunoblot loading control methodology. Analytical biochemistry. 2012;430:108–10. https://doi.org/10.1016/j.ab.2012.08.015
Ma L, Gao C, Mao Z, Zhou J, Shen J, Hu X, et al. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials. 2003;24:4833–41.
Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatologic Surgery. 2010;36(s3):1859–65.
Anitua E, Sánchez M, Orive G, Andia I. Delivering growth factors for therapeutics. Trends in pharmacological sciences. 2008;29:37–41.
Qiu M, Chen D, Shen C, Shen J, Zhao H, He Y. Platelet-Rich Plasma-Loaded Poly (D, L-lactide)-Poly (ethylene glycol)-Poly (D, L-lactide) Hydrogel Dressing Promotes Full-Thickness Skin Wound Healing in a Rodent Model. International journal of molecular sciences. 2016;17:1001.
Lu B, Wang T, Li Z, Dai F, Lv L, Tang F, et al. Healing of skin wounds with a chitosan–gelatin sponge loaded with tannins and platelet-rich plasma. International journal of biological macromolecules. 2016;82:884–91.
Almeida H, Eswaramoorthy R, Cunniffe G, Buckley C, O’Brien F, Kelly D. Fibrin hydrogels functionalized with cartilage extracellular matrix and incorporating freshly isolated stromal cells as an injectable for cartilage regeneration. Acta biomaterialia. 2016;36:55–62.
Russo F, D’Este M, Vadalà G, Cattani C, Papalia R, Alini M, et al. Platelet rich plasma and hyaluronic acid blend for the treatment of osteoarthritis: Rheological and biological evaluation. PloS one. 2016;11:e0157048.
Lanza R, Langer R, Vacanti JP Principles of tissue engineering. Academic press; 2011.
Ratner BD, Bryant SJ. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng. 2004;6:41–75.
Clark A, Saunderson D, Suggett A. Infrared and laser‐Raman spectroscopic studies of thermally‐induced globular protein gels. International journal of peptide and protein research. 1981;17:353–64.
Sullivan ST, Tang C, Kennedy A, Talwar S, Khan SA. Electrospinning and heat treatment of whey protein nanofibers. Food Hydrocolloids. 2014;35:36–50.
Wetzel R, Becker M, Behlke J, Billwitz H, Böhm S, Ebert B, et al. Temperature behaviour of human serum albumin. European Journal of Biochemistry. 1980;104:469–78.
Ferrero-Gutierrez A, Menendez-Menendez Y, Alvarez-Viejo M, Meana A, Otero J. New serum-derived albumin scaffold seeded with adipose-derived stem cells and olfactory ensheathing cells used to treat spinal cord injured rats. Histol Histopathol. 2013;28:89–100.
Gallego L, Junquera L, García E, García V, Álvarez-Viejo M, Costilla S, et al. Repair of rat mandibular bone defects by alveolar osteoblasts in a novel plasma-derived albumin scaffold. Tissue Engineering Part A. 2010;16:1179–87.
Kretlow JD, Klouda L, Mikos AG. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev. 2007;59:263–73. https://doi.org/10.1016/j.addr.2007.03.013
Wang H-M, Chou Y-T, Wen Z-H, Wang Z-R, Chen C-H, Ho M-L. Novel biodegradable porous scaffold applied to skin regeneration. PloS one. 2013;8:e56330.
Fanali G, di Masi A, Trezza V, Marino M, Fasano M, Ascenzi P. Human serum albumin: from bench to bedside. Molecular aspects of medicine. 2012;33:209–90.
Falcone SJ, Berg RA. Crosslinked hyaluronic acid dermal fillers: a comparison of rheological properties. Journal of biomedical materials research Part A. 2008;87:264–71. https://doi.org/10.1002/jbm.a.31675
Jalowiec JM, D’Este M, Bara JJ, Denom J, Menzel U, Alini M, et al. An in vitro investigation of platelet-rich plasma-gel as a cell and growth factor delivery vehicle for tissue engineering. Tissue Engineering Part C: Methods. 2015;22:49–58.
Nimal T, Baranwal G, Bavya M, Biswas R, Jayakumar R. Anti-staphylococcal Activity of Injectable Nano Tigecycline/Chitosan-PRP Composite Hydrogel Using Drosophila melanogaster Model for Infectious Wounds. ACS applied materials & interfaces. 2016;8:22074–83.
Anitua E, Prado R, Azkargorta M, Rodriguez‐Suárez E, Iloro I, Casado‐Vela J, et al. High‐throughput proteomic characterization of plasma rich in growth factors (PRGF–Endoret)‐derived fibrin clot interactome. Journal of tissue engineering and regenerative medicine. 2015;9:E1–E12.
Anitua E, Zalduendo M, Prado R, Alkhraisat M, Orive G. Morphogen and proinflammatory cytokine release kinetics from PRGF‐Endoret fibrin scaffolds: Evaluation of the effect of leukocyte inclusion. Journal of Biomedical Materials Research Part A. 2015;103:1011–20.
Anitua E, Troya M, Zalduendo M, Tejero R, Orive G. Progress in the Use of Autologous Regenerative Platelet-based Therapies in Implant Dentistry. Current pharmaceutical biotechnology. 2016;17:402–13.
Anitua E, Muruzabal F, Pino A, Merayo-Lloves J, Orive G. Biological stability of plasma rich in growth factors eye drops after storage of 3 months. Cornea. 2013;32:1380–6.
Anitua E, Pino A, Orive G. Plasma rich in growth factors promotes dermal fibroblast proliferation, migration and biosynthetic activity. Journal of Wound Care. 2016;25:680–7.
Anitua E, Troya M, Orive G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-β1-induced myodifferentiation. Journal of periodontology. 2012;83:1028–37.
Anitua E, Pino A, Jaen P, Orive G. Plasma Rich in Growth Factors Enhances Wound Healing and Protects from Photo-oxidative Stress in Dermal Fibroblasts and 3D Skin Models. Current pharmaceutical biotechnology. 2016;17:556–70.
Anitua E, Pino A, Orive G. Plasma Rich in Growth Factors Inhibits Ultraviolet B Induced Photoageing of the Skin in Human Dermal Fibroblast Culture. Current pharmaceutical biotechnology. 2016;17:1068–78.
Wynn T. Cellular and molecular mechanisms of fibrosis. The Journal of pathology. 2008;214:199–210.
Anitua E, Zalduendo M, Troya M, Padilla S, Orive G. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PloS one. 2015;10:e0121713.
Vyas B, Ishikawa K, Duflo S, Chen X, Thibeault SL. Inhibitory effects of hepatocyte growth factor and interleukin-6 on transforming growth factor-beta1 mediated vocal fold fibroblast-myofibroblast differentiation. The Annals of otology, rhinology, and laryngology. 2010;119:350–7.
Li ZJ, Choi HI, Choi DK, Sohn KC, Im M, Seo YJ, et al. Autologous platelet‐rich plasma: a potential therapeutic tool for promoting hair growth. Dermatologic Surgery. 2012;38(7pt1):1040–6.
Tohidnezhad M, Wruck C-J, Slowik A, Kweider N, Beckmann R, Bayer A, et al. Role of platelet-released growth factors in detoxification of reactive oxygen species in osteoblasts. Bone. 2014; 65:9–17.
Rastegar H, Ahmadi Ashtiani H, Aghaei M, Ehsani A, Barikbin B. Combination of herbal extracts and platelet‐rich plasma induced dermal papilla cell proliferation: involvement of ERK and Akt pathways. Journal of cosmetic dermatology. 2013;12:116–22.
Shen H, Cheng H, Chen H, Zhang J. Identification of key genes induced by platelet-rich plasma in human dermal papilla cells using bioinformatics methods. Molecular Medicine Reports. 2017;15:81–8.
Martínez CE, Smith PC, Palma Alvarado VA. The influence of platelet-derived products on angiogenesis and tissue repair: a concise update. Frontiers in physiology. 2015;6:290.
Tang Y-Q, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infection and immunity. 2002;70:6524–33.
Yeaman MR. The role of platelets in antimicrobial host defense. Clinical infectious diseases. 1997;25:951–68.
Anitua E, Alonso R, Girbau C, Aguirre J, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF®‐Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clinical and experimental dermatology. 2012;37:652–7.
Chen L, Wang C, Liu H, Liu G, Ran X Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro. Journal of Diabetes Research. 2013;2013:269527. https://doi.org/10.1155/2013/269527.
Acknowledgements
This research has received specific grants from the funding agency of the Basque Country Government (Spain) under the research and development project Gaitek (IG-2015/00355) and Hazitek (ZL-2016/00411). Eduardo Anitua is the scientific director of, and Ander Pino, María Troya and Gorka Orive are researchers at BTI Biotechnology Institute, the company that has developed the PRGF-Endoret technology.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Anitua, E., Pino, A., Troya, M. et al. A novel personalized 3D injectable protein scaffold for regenerative medicine. J Mater Sci: Mater Med 29, 7 (2018). https://doi.org/10.1007/s10856-017-6012-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10856-017-6012-6